(Q48185417)

9 February 2018

title

[125I]CGP 42112 reveals a non-angiotensin II binding site in 1-methyl-4-phenylpyridine (MPP+)-induced brain injury. (English)

1 reference

9 February 2018

author

Ruey-Meei Wu

3

1 reference

9 February 2018

author name string

M Viswanathan

1

1 reference

9 February 2018

A M de Oliveira

2

1 reference

9 February 2018

C C Chiueh

4

1 reference

9 February 2018

J M Saavedra

5

1 reference

9 February 2018

publication date

1 February 1994

1 reference

9 February 2018

Cellular and Molecular Neurobiology

published in

1 reference

9 February 2018

volume

14

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

99-104

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/bf02088592

exact match

0 references

cites work

Radioiodinated CGP 42111A: A novel high affinity and highly selective ligand for the characterization of angiotensin AT2 receptors

1 reference

12 December 2020

Peptides released by ameboid microglia regulate astroglial proliferation

1 reference

12 December 2020

Macrophages and the Nervous System

1 reference

12 December 2020

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

12 December 2020

Reactive glia as rivals in regulating neuronal survival.

1 reference

12 December 2020

Balloon angioplasty enhances the expression of angiotensin II AT1 receptors in neointima of rat aorta

1 reference

12 December 2020

The kinetics and morphological characteristics of the macrophage-microglial response to kainic acid-induced neuronal degeneration

1 reference

12 December 2020

Pargyline Prevents MPTP-Induced Parkinsonism in Primates

1 reference

12 December 2020

Angiotensin II receptors and angiotensin II receptor antagonists.

1 reference

12 December 2020

Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications.

1 reference

12 December 2020

Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.

1 reference

12 December 2020

The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

12 December 2020

Insulin-like growth factors in the response to cerebral ischemia.

1 reference

12 December 2020

Characterization of brain angiotensin II AT2 receptor subtype using [125I] CGP 42112A.

1 reference

12 December 2020

Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization

1 reference

12 December 2020

Visualization of interleukin-2-like molecules in MPP(+)-lesioned rat brain

1 reference

12 December 2020

Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord

1 reference

12 December 2020

The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain

1 reference

12 December 2020

Brain and Pituitary Angiotensin

1 reference

12 December 2020

Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing

1 reference

12 December 2020

Changes in skin angiotensin II receptors in rats during wound healing.

1 reference

12 December 2020

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

12 December 2020

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02088592

1 reference

9 February 2018

PubMed ID

7954664

1 reference

9 February 2018